Dianthus Therapeutics, Inc. short interest in 2025
In 2025, Dianthus Therapeutics, Inc.'s disclosed short interest ran from 20.02% of shares outstanding on 15 Jan 2025 to 14.31% on 31 Dec 2025, a change of -5.71 percentage points. The year's high was 21.33% on 30 Jun 2025 and its low 8.66% on 28 Nov 2025, averaging 16.76% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.67 days on 31 Jan 2025. Full history: Dianthus Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 20.02% (15 Jan 2025)
- End of year
- 14.31% (31 Dec 2025)
- Change
- -5.71 pp
- High
- 21.33% (30 Jun 2025)
- Low
- 8.66% (28 Nov 2025)
- Average
- 16.76%
- Highest days to cover
- 27.67 (31 Jan 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 20.02% | 17.33 | |
| 31 Jan 2025 | 19.97% | 27.67 | |
| 14 Feb 2025 | 17.94% | 25.53 | |
| 28 Feb 2025 | 18.32% | 24.02 | |
| 14 Mar 2025 | 17.34% | 22.83 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 16.46% | 10.91 | |
| 15 Apr 2025 | 18.37% | 10.84 | |
| 30 Apr 2025 | 19.31% | 23.07 | |
| 15 May 2025 | 19.83% | 26.76 | 10-Q filed, results (8-K) |
| 30 May 2025 | 19.95% | 23.52 | |
| 13 Jun 2025 | 20.81% | 22.79 | |
| 30 Jun 2025 | 21.33% | 23.11 | |
| 15 Jul 2025 | 19.00% | 14.80 | |
| 31 Jul 2025 | 19.92% | 20.08 | |
| 15 Aug 2025 | 18.59% | 18.05 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 17.33% | 13.04 | |
| 15 Sep 2025 | 15.92% | 3.41 | |
| 30 Sep 2025 | 15.41% | 6.76 | |
| 15 Oct 2025 | 11.63% | 6.12 | |
| 31 Oct 2025 | 12.51% | 8.49 | results (8-K) |
| 14 Nov 2025 | 9.52% | 6.51 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 8.66% | 4.05 | |
| 15 Dec 2025 | 9.71% | 7.84 | |
| 31 Dec 2025 | 14.31% | 8.18 |
See also: Dianthus Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.